AGM/EGM10 Jul 2026, 04:28 pm
Alembic Pharma Files Annual Report for FY26
AI Summary
Alembic Pharmaceuticals Ltd has filed its Annual Report for the financial year ended March 31, 2026, as per SEBI regulations. The report includes the notice of the Annual General Meeting. The integrated annual report, themed 'Catalysing opportunities Strengthening growth', covers various aspects of the company's performance and strategy, including highlights of FY26, Chairman's and Managing Directors' statements, sectoral and business performance, business strategy, risk management, sustainability goals, stakeholder engagement, materiality assessment, value creation model, and financial capital.
Key Highlights
- Annual Report for FY ended March 31, 2026, has been filed.
- Report includes notice of the Annual General Meeting.
- Covers business strategy and risk management.
- Details sustainability goals and stakeholder engagement.
- Financial capital and value creation model discussed.
Price Impact
More from APLLTD